Largest biotech companies by earnings
Net income for the latest fiscal year: what was left for shareholders after every cost, interest and tax. A negative figure is a loss.
Gilead Sciences leads the 24 biotech companies ranked by earnings, at NOK 82.5B, ahead of Amgen (NOK 74.8B) and Biogen (NOK 12.5B). Figures as of 18 Nov 2026, 20:14 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 24
- First
- Gilead SciencesNOK 82.5B
- Median
- -NOK 665M
- Combined market value
- NOK 8.12T
- Countries
- 5
Market values as of .
All countries▾
All sectors▾
Biotech▾
| # | Company | Earnings ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | Gilead SciencesGILD · Health Care | NOK 82.5B | NOK 2.03T | NOK 1,638.63 | 0.74% down | 33% up | ||
| 2 | AmgenAMGN · Health Care | NOK 74.8B | NOK 2.33T | NOK 4,301.23 | 3.12% down | 34% up | ||
| 3 | BiogenBIIB · Health Care | NOK 12.5B | NOK 358.2B | NOK 2,423.26 | 0.34% down | 49% up | ||
| 4 | argenxARGX · Health Care | NOK 12.5B | NOK 575.9B | NOK 9,157.20 | 0.32% down | 4% up | ||
| 5 | ExelixisEXEL · Health Care | NOK 7.6B | NOK 162.1B | NOK 664.45 | 0.04% up | 63% up | ||
| 6 | Neurocrine BiosciencesNBIX · Health Care | NOK 4.6B | NOK 159.9B | NOK 1,579.92 | 1.79% down | 20% up | ||
| 7 | QiagenQGEN · Health Care | NOK 4.1B | NOK 99.3B | NOK 480.96 | 0.29% down | 12% up | ||
| 8 | Halozyme TherapeuticsHALO · Health Care | NOK 3.1B | NOK 106.3B | NOK 932.15 | 0.18% up | 37% up | ||
| 9 | Krystal BiotechKRYS · Health Care | NOK 2B | NOK 90.2B | NOK 3,044.27 | 5.17% up | 46% up | ||
| 10 | Bio-TechneTECH · Health Care | NOK 1.8B | NOK 110.9B | NOK 705.71 | 0.21% up | 26% up | ||
| 11 | RepligenRGEN · Health Care | NOK 474.1M | NOK 107.1B | NOK 1,674.75 | 6.51% up | 5% up | ||
| 12 | Adaptive BiotechnologiesADPT · Health Care | -NOK 576.9M | NOK 44.9B | NOK 277.30 | 0.39% up | 88% up | ||
| 13 | Twist BioscienceTWST · Health Care | -NOK 753.1M | NOK 77.1B | NOK 1,130.52 | 4.11% up | 340% up | ||
| 14 | CG OncologyCGON · Health Care | -NOK 1.6B | NOK 69.4B | NOK 776.63 | 1.47% up | 85% up | ||
| 15 | Kodiak SciencesKOD · Health Care | -NOK 2.2B | NOK 61.8B | NOK 944.29 | 0.61% up | 396% up | ||
| 16 | Kymera TherapeuticsKYMR · Health Care | -NOK 3B | NOK 100.4B | NOK 1,175.71 | 0.21% down | 87% up | ||
| 17 | ImmunityBioIBRX · Health Care | -NOK 3.4B | NOK 68.9B | NOK 64.74 | 6.67% up | 193% up | ||
| 18 | Scholar Rock HoldingSRRK · Health Care | -NOK 3.7B | NOK 56.8B | NOK 465.69 | 6.54% up | 14% up | ||
| 19 | ImmunovantIMVT · Health Care | -NOK 4.9B | NOK 66.9B | NOK 323.45 | 0.45% up | 43% up | ||
| 20 | CRISPR TherapeuticsCRSP · Health Care | -NOK 5.6B | NOK 38.1B | NOK 393.16 | 1.00% up | 21% down | ||
| 21 | VaxcytePCVX · Health Care | -NOK 7.4B | NOK 89.8B | NOK 567.30 | 1.50% down | 22% up | ||
| 22 | Revolution MedicinesRVMD · Health Care | -NOK 11B | NOK 335.1B | NOK 1,549.24 | 1.79% down | 131% up | ||
| 23 | BioNTechBNTX · Health Care | -NOK 12.2B | NOK 201B | NOK 810.66 | 1.47% down | 16% down | ||
| 24 | ModernaMRNA · Health Care | -NOK 27.4B | NOK 778.1B | NOK 1,923.06 | 4.09% down | 755% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Earnings is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 9.6958 NOK).
Questions and answers
Which biotech companies rank first by earnings?
Gilead Sciences (NOK 82.5B), Amgen (NOK 74.8B) and Biogen (NOK 12.5B) are the top three of the 24 biotech companies ranked by earnings as of 18 Nov 2026, 20:14 UTC.
How many biotech companies are in this ranking?
24 are ranked by earnings.
What are these biotech companies worth together?
The 24 biotech companies ranked by earnings have a combined market value of NOK 8.12T as of 18 Nov 2026, 20:14 UTC.
What does ranking by earnings measure?
Net income for the latest fiscal year: what was left for shareholders after every cost, interest and tax. A negative figure is a loss.
Learn how this ranking works
All markets guides →- Revenue vs earnings vs free cash flow: what each tells you
Revenue is everything a company sold in a period. Earnings, or net income, is what remains after every cost, interest and tax. Free cash flow is the cash operations brought in minus spending on long-lived assets. Revenue shows size and demand, earnings show profitability, and free cash flow shows how much cash the business can actually hand out.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
- How companies are sorted into sectors and industries
Companies are sorted into sectors and industries by classification systems. The index providers MSCI and S&P Dow Jones Indices use GICS: 11 sectors split into 25 industry groups, 74 industries and 163 sub-industries. SEC filings carry a four-digit SIC code. The two can place one company differently, because each looks at the business from its own angle.
Cite this page
Funkfolio, “Largest biotech companies by earnings”, data as of 18 November 2026. https://funkfolio.com/companies/category/biotech?by=earnings
Underlying data: Yahoo Finance; SEC EDGAR.